We aim our entrepreneurial talent on the practical innovation of healthcare technologies and businesses.
DFB Pharmaceuticals is a private investment and development group focused on building healthcare and life science operating businesses, technologies, and products. Since 1990, DFB and its principals have established a successful track record of creating value by building businesses through strategic acquisitions, product development, brand building, and operational excellence.
Businesses
Nanology
Our clinical-stage oncology company targets cancer therapies directly into solid tumors to increase their clinical benefit without the toxicity associated with systemic cancer therapies.
Phyton biotech
We own and operate Phyton Biotech®, the world’s first and only company to harness plant cell fermentation (PCF®) technology for development and commercialization of plant-derived pharmaceuticals, and the world’s largest commercial provider of high-quality Paclitaxel and Docetaxel API via PCF®.
Let's talk.
Use the form below to contact us. We will get back to you as soon as possible. We look forward to hearing from you.